Résection vasculaire et cancers annexiels : à propos de 2 cas
暂无分享,去创建一个
É. Gardet | J. Monteil | Y. Aubard | N. Tubiana | T. Gauthier | A. Lacorre | J. Berger | O. Loum
[1] Y. Korogi,et al. Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy , 2012, Journal of radiation research.
[2] P. Morice,et al. [The age of the patient over 70 is a contraindication to perform para-aortic lymphadenectomy for ovarian cancer]. , 2012, Gynecologie, obstetrique & fertilite.
[3] Sung-Sik Han,et al. Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer. , 2011, Gynecologic oncology.
[4] C. Pomel,et al. Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer. , 2011, Gynecologic oncology.
[5] T. Goto,et al. Potential Survival Benefit of Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers , 2010, International Journal of Gynecologic Cancer.
[6] D. Levine,et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. , 2010, Gynecologic oncology.
[7] G. Kenter,et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. , 2010, The New England journal of medicine.
[8] A. Gadducci,et al. The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study. , 2010, Gynecologic oncology.
[9] D. Levine,et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. , 2009, Gynecologic oncology.
[10] C. Haie-meder,et al. [Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ]. , 2008, Gynecologie, obstetrique & fertilite.
[11] J. Mandrekar,et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. , 2006, The Journal of infection.
[12] J. Classe,et al. Récidives locorégionales du cancer de l’ovaire : place de la chirurgie , 2004 .
[13] R. Gornall,et al. Resection of recurrent bulky gynaecological side wall malignancy with iliac vessel reconstruction , 2001, BJOG : an international journal of obstetrics and gynaecology.
[14] D. Chi,et al. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. , 2011, Gynecologic oncology.
[15] M. Nechushkin,et al. [Resection and prosthetics of abdominal aorta by surgical treatment of invasive retroperitoneal tumors]. , 2010, Khirurgiia.